[DOI] [PMC free article] [PubMed] [Google Scholar] 52.Gratacs J, Galndez E, Otn T
The International Foundation first conducted this survey in January 2024
"Additionally, Blue Cross will end coverage of GLP-1 drugs for weight loss for large group fully insured members beginning January 1, 2025, or on a group's 2025 health coverage renewal date
Inhibitors of HBx production (siRNA), specific HBx inhibitors, and IFN inhibited luciferase production, whereas antivirals with no effect on protein production (tenofovir) had no effect
New studies from 23andMe suggest genetic variation may modestly influence GLP-1 weight-loss response and side effects
Discarding damaged pens and obtaining fresh supplies from your pharmacy is the only safe approach, though this creates cost and access friction